251 related articles for article (PubMed ID: 34638813)
1. Treatment of Sjögren's Syndrome with Mesenchymal Stem Cells: A Systematic Review.
Chihaby N; Orliaguet M; Le Pottier L; Pers JO; Boisramé S
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638813
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease.
Khalili S; Liu Y; Kornete M; Roescher N; Kodama S; Peterson A; Piccirillo CA; Tran SD
PLoS One; 2012; 7(6):e38615. PubMed ID: 22685592
[TBL] [Abstract][Full Text] [Related]
3. Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren's syndrome by inducing regulatory T cells.
Liu Y; Li C; Wang S; Guo J; Guo J; Fu J; Ren L; An Y; He J; Li Z
Mod Rheumatol; 2021 Jan; 31(1):186-196. PubMed ID: 31859545
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren's Syndrome-Like Disease.
Abughanam G; Elkashty OA; Liu Y; Bakkar MO; Tran SD
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557796
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Labial Gland Mesenchymal Stem Cells of Healthy Individuals and Patients with Sjögren's Syndrome: A Preliminary Study.
Wang SQ; Wang YX; Hua H
Stem Cells Dev; 2017 Aug; 26(16):1171-1185. PubMed ID: 28537471
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
Soyfoo MS; Chivasso C; Perret J; Delporte C
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stem Cell Enhances the Function of MDSCs in Experimental Sjögren Syndrome.
Tian J; Hong Y; Zhu Q; Zhou H; Zhang Y; Shen Z; Guo H; Zhang Y; Ai X; Zhao F; Rui K; Xu H; Wang S
Front Immunol; 2020; 11():604607. PubMed ID: 33414787
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells.
Shi B; Qi J; Yao G; Feng R; Zhang Z; Wang D; Chen C; Tang X; Lu L; Chen W; Sun L
Stem Cell Res Ther; 2018 Nov; 9(1):308. PubMed ID: 30409219
[TBL] [Abstract][Full Text] [Related]
9. Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells.
Li B; Xing Y; Gan Y; He J; Hua H
Stem Cell Res Ther; 2021 Aug; 12(1):478. PubMed ID: 34446113
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis.
Yao G; Qi J; Liang J; Shi B; Chen W; Li W; Tang X; Wang D; Lu L; Chen W; Shi S; Hou Y; Sun L
Theranostics; 2019; 9(26):8253-8265. PubMed ID: 31754394
[No Abstract] [Full Text] [Related]
11. Gene therapeutics in Sjögren's syndrome.
Bolstad AI; Jonsson R
Expert Opin Biol Ther; 2005 Jun; 5(6):763-72. PubMed ID: 15952907
[TBL] [Abstract][Full Text] [Related]
12. Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren's syndrome by modulating the function of myeloid-derived suppressor cells.
Rui K; Hong Y; Zhu Q; Shi X; Xiao F; Fu H; Yin Q; Xing Y; Wu X; Kong X; Xu H; Tian J; Wang S; Lu L
Cell Mol Immunol; 2021 Feb; 18(2):440-451. PubMed ID: 33408339
[TBL] [Abstract][Full Text] [Related]
13. Compact Bone-Derived Multipotent Mesenchymal Stromal Cells (MSCs) for the Treatment of Sjogren's-like Disease in NOD Mice.
Elghanam GA; Liu Y; Khalili S; Fang D; Tran SD
Methods Mol Biol; 2017; 1553():25-39. PubMed ID: 28229405
[TBL] [Abstract][Full Text] [Related]
14. Cytokines in Sjögren's syndrome.
Roescher N; Tak PP; Illei GG
Oral Dis; 2009 Nov; 15(8):519-26. PubMed ID: 19519622
[TBL] [Abstract][Full Text] [Related]
15. Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice.
Yin H; Cabrera-Perez J; Lai Z; Michael D; Weller M; Swaim WD; Liu X; Catalán MA; Rocha EM; Ismail N; Afione S; Rana NA; Di Pasquale G; Alevizos I; Ambudkar I; Illei GG; Chiorini JA
Arthritis Rheum; 2013 Dec; 65(12):3228-38. PubMed ID: 23982860
[TBL] [Abstract][Full Text] [Related]
16. Advances in mesenchymal stem cell-derived extracellular vesicles therapy for Sjogren's syndrome-related dry eye disease.
Li SJ; Cheng RJ; Wei SX; Xia ZJ; Pu YY; Liu Y
Exp Eye Res; 2023 Dec; 237():109716. PubMed ID: 37951337
[TBL] [Abstract][Full Text] [Related]
17. Inflammation in Sjögren's syndrome: Cause or consequence?
Rodrigues AR; Soares R
Autoimmunity; 2017 May; 50(3):141-150. PubMed ID: 28276715
[TBL] [Abstract][Full Text] [Related]
18. Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice.
Li N; Shigihara T; Tzioufas AG; Notkins AL; Yoon JW; Jun HS
Arthritis Rheum; 2007 Jul; 56(7):2211-5. PubMed ID: 17599739
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow cells are a source of undifferentiated cells to prevent Sjögren's syndrome and to preserve salivary glands function in the non-obese diabetic mice.
Khalili S; Liu Y; Sumita Y; Maria OM; Blank D; Key S; Mezey E; Tran SD
Int J Biochem Cell Biol; 2010 Nov; 42(11):1893-9. PubMed ID: 20732442
[TBL] [Abstract][Full Text] [Related]
20. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]